SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-020265
Filing Date
2018-03-27
Accepted
2018-03-27 07:46:28
Documents
4
Period of Report
2018-03-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-9065_18k.htm 8-K 25927
2 EX-99.1 a18-9065_1ex99d1.htm EX-99.1 33061
3 GRAPHIC g90651mmi001.jpg GRAPHIC 2088
4 GRAPHIC g90651mmi002.gif GRAPHIC 25425
  Complete submission text file 0001104659-18-020265.txt   98335
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 18714101
SIC: 2834 Pharmaceutical Preparations